Martinotti, Giovanni
 Distribuzione geografica
Continente #
EU - Europa 6.913
NA - Nord America 3.549
AS - Asia 1.204
OC - Oceania 33
SA - Sud America 28
AF - Africa 21
Continente sconosciuto - Info sul continente non disponibili 4
Totale 11.752
Nazione #
US - Stati Uniti d'America 3.491
IT - Italia 3.262
DE - Germania 1.583
SE - Svezia 533
CN - Cina 524
UA - Ucraina 408
SG - Singapore 307
FR - Francia 265
GB - Regno Unito 232
IE - Irlanda 171
ID - Indonesia 108
FI - Finlandia 96
IN - India 91
RU - Federazione Russa 84
TR - Turchia 55
CH - Svizzera 51
NL - Olanda 46
CA - Canada 42
AU - Australia 28
ES - Italia 28
BE - Belgio 27
HK - Hong Kong 26
JP - Giappone 22
RO - Romania 22
IR - Iran 20
BR - Brasile 19
CI - Costa d'Avorio 13
PL - Polonia 13
HU - Ungheria 12
AL - Albania 11
CZ - Repubblica Ceca 11
MX - Messico 9
AT - Austria 8
MT - Malta 7
VN - Vietnam 7
HR - Croazia 6
IL - Israele 6
LT - Lituania 6
PT - Portogallo 6
TH - Thailandia 6
NZ - Nuova Zelanda 5
CL - Cile 4
KZ - Kazakistan 4
MY - Malesia 4
TW - Taiwan 4
AM - Armenia 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
GR - Grecia 3
MC - Monaco 3
NO - Norvegia 3
NP - Nepal 3
PE - Perù 3
TN - Tunisia 3
BG - Bulgaria 2
EE - Estonia 2
EU - Europa 2
KR - Corea 2
LU - Lussemburgo 2
PH - Filippine 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BO - Bolivia 1
BY - Bielorussia 1
DZ - Algeria 1
GL - Groenlandia 1
GT - Guatemala 1
IM - Isola di Man 1
IQ - Iraq 1
JM - Giamaica 1
JO - Giordania 1
KH - Cambogia 1
KW - Kuwait 1
LK - Sri Lanka 1
LV - Lettonia 1
MA - Marocco 1
MD - Moldavia 1
MM - Myanmar 1
MZ - Mozambico 1
NG - Nigeria 1
PK - Pakistan 1
PS - Palestinian Territory 1
PY - Paraguay 1
RS - Serbia 1
SM - San Marino 1
TT - Trinidad e Tobago 1
VA - Santa Sede (Città del Vaticano) 1
ZA - Sudafrica 1
Totale 11.752
Città #
Chandler 767
Milan 388
Rome 297
Singapore 237
Ashburn 224
Jacksonville 209
San Mateo 189
Dublin 166
Wilmington 147
Nanjing 122
Jakarta 104
Woodbridge 97
Dearborn 83
New York 79
Nürnberg 76
Ann Arbor 67
Redwood City 67
Boston 65
Moscow 57
Lawrence 56
Marseille 55
Seattle 51
Houston 50
Bremen 49
Norwalk 49
Nanchang 48
Turin 47
Bologna 46
Florence 44
Lancaster 42
Naples 42
Fairfield 41
Princeton 39
Munich 37
Cattolica 34
Falls Church 32
University Park 30
Catania 29
Guangzhou 28
Bari 27
Mountain View 27
Beijing 26
Changsha 26
Verona 26
Genoa 25
Hebei 24
Izmir 23
Boardman 22
Brescia 22
Los Angeles 22
Paris 22
Tianjin 22
Hangzhou 20
Palermo 20
Shenyang 20
Brussels 19
Shanghai 19
Cambridge 18
Chicago 18
Fremont 18
Pune 18
Padova 17
Torino 16
Jiaxing 15
Kunming 15
Abidjan 13
Hefei 13
Messina 13
Pisa 13
London 12
Toronto 12
Augusta 11
Bergamo 11
Columbus 11
Helsinki 11
Hong Kong 11
Kish 11
Leawood 11
Parma 11
Tirana 11
Kowloon 10
Modena 10
Philadelphia 10
Cagliari 9
Livorno 9
Ottawa 9
Redmond 9
Simi Valley 9
Taranto 9
Udine 9
Zurich 9
Andover 8
Edinburgh 8
Jesi 8
Lucca 8
Perugia 8
Trento 8
Caserta 7
Frankfurt am Main 7
Lugano 7
Totale 5.183
Nome #
L efficacia del topiramato a basso dosaggio in pazienti alcolisti in fase di post-disintossicazione 2.207
Psychometric characteristic of the Italian version of the Temperament and Character Inventory--revised, personality, psychopathology, and attachment styles 587
Quetiapine as add-on treatment for Bipolar I Disorder with comorbid compulsive buying and physical exercise addiction 427
Craving Typology Questionnaire (CTQ): a scale for alcohol craving in normal controls and alcoholics 312
Comorbilità tra Disturbi da Uso di Sostanze e disturbi affettivi 310
Bipolar disorder and gambling disorder comorbidity: current evidence and implications for pharmacological treatment 272
Pregabalin versus naltrexone in alcohol dependence: a randomised, double-blind, comparison trial 207
Description and validation of a questionnaire for the detection of meteoropathy and meteorosensitivity: the METEO-Q 188
Behavioural addictions in bipolar disorder patients: Role of impulsivity and personality dimensions 183
Pregabalin, tiapride and lorazepam in alcohol withdrawal syndrome: a multi-centre, randomized, single-blind comparison trial. 154
Problematic mobile phone use in adolescence: A cross-sectional study 143
Bipolar disorder: "pure" versus mixed depression over a 1-year follow-up. 142
[Diagnosis of deficit and attention/hyperactivity disorders (ADHD) in patients with bipolar or unipolar depression: an experimental study] 138
Low-dose topiramate in alcohol dependence: a single-blind, placebo-controlled study 129
Role of Substance Abuse Comorbidity and Personality on the Outcome of Depression in Bipolar Disorder: Harm Avoidance Influences Medium-Term Treatment Outcome. 121
[Diagnosis of deficit and attention/hyperactivity disorders (ADHD) in patients with bipolar or unipolar depression: an experimental study]. 119
Bipolar disorder: "pure" versus mixed depression over a 1-year follow-up 117
Adult attention-deficit/hyperactivity disorder in major depressed and bipolar subjects: role of personality traits and clinical implications 113
Factors associated with the course of symptoms in bipolar disorder during a 1-year follow-up: depression vs. sub-threshold mixed state 112
Alcohol protracted withdrawal syndrome: the role of anhedonia 110
Behavioural addictions in adolescents and young adults: results from a prevalence study. 109
Role of substance abuse comorbidity and personality on the outcome of depression in bipolar disorder: harm avoidance influences medium-term treatment outcome 106
Il trattamento della schizofrenia 106
Clinical features, response to treatment and functional outcome of bipolar disorder patients with and without co-occurring substance use disorder: 1-year follow-up 104
Anhedonia in Parkinson's disease patients with and without pathological gambling: A case-control study 103
Topiramate in Alcohol Use Disorders: Review and Update. 101
Pregabalin in outpatient detoxification of subjects with mild-to-moderate alcohol withdrawal syndrome. 100
The assessment of post-detoxification anhedonia: influence of clinical and psychosocial variables 100
Suicide by pencil 99
Pregabalin augmentation in treatment-resistant obsessive-compulsive disorder: a 16-week case series 98
Bipolar disorder: "pure" versus mixed depression over a 1-year follow-up 98
PRELIMINARY ANALYSIS OF GENES INVOLVED IN INFLAMMATORY, OXIDATIVE PROCESSES AND CA2+SIGNALING IN BIPOLAR DISORDER AND COMORBIDITY FOR SUBSTANCE USE DISORDER 97
Who`s the Leader, Mania or Depression? Predominant Polarity and Alcohol/Polysubstance Use in Bipolar Disorders 96
Acetyl-L-carnitine for alcohol craving and relapse prevention in anhedonic alcoholics: a randomized, double-blind, placebo-controlled pilot trial. 95
Targeting the glutamatergic system to treat pathological gambling: current evidence and future perspectives 94
Further evidence supporting the association between 5HTR2C gene and bipolar disorder 93
Serotoninergic and dopaminergic genes in bipolar disorder and response to treatments in bipolar depression. Investigation on a well-characterized naturalistic sample 92
Acetyl-l-Carnitine in the treatment of anhedonia, melancholic and negative symptoms in alcohol dependent subjects 90
Amantadine in the treatment of pathological gambling: a case report 90
Oxcarbazepine in bipolar disorder: a critical review of the literature 89
Gender Differences and Psychopathological Features Associated With Addictive Behaviors in Adolescents. 89
Further evidence supporting the influence of brain-derived neurotrophic factor on the outcome of bipolar depression: independent effect of brain-derived neurotrophic factor and harm avoidance 88
Aripiprazole, alcohol and substance abuse: a review 88
Aripiprazole in the treatment of patients with alcohol dependence: a double-blind, comparison trial vs. naltrexone 87
Reduced hedonic capacity in euthymic bipolar subjects: a trait-like feature? 86
A possible new option for migraine management: agomelatine 86
Acetyl-L-Carnitine in the management of pain during methadone withdrawal syndrome 85
Dead under the bed: a case of Diogenes syndrome? 85
Allostasis as a conceptual framework linking bipolar disorder and addiction 85
Antidepressant treatment restores brain-derived neurotrophic factor serum levels and ameliorates motor function in Parkinson disease patients 84
Punding in non-demented Parkinson's disease patients: Relationship with psychiatric and addiction spectrum comorbidity 83
Oxcarbazepine improves mood in patients with epilepsy 82
Cocaine use disorders and serum magnesium profile 82
Behavioural addictions in adolescents and young adults: results from a prevalence study 81
Oxcarbazepine improves mood in patients with epilepsy. 80
Enhanced BDNF serum levels in patients with severe pathological gambling 80
Enhanced BDNF serum levels in patients with severe pathological gambling 80
Neural correlates of cognitive control in gambling disorder: a systematic review of fMRI studies 80
Plasma levels of n-3 fatty acids in bipolar patients: Deficit restricted to DHA 79
Dopaminergic and clinical correlates of high-frequency repetitive transcranial magnetic stimulation in gambling addiction: a SPECT case study. 77
Agomelatine increases BDNF serum levels in depressed patients in correlation with the improvement of depressive symptoms 76
The emerging role of melatonin agonists in the treatment of major depression: focus on agomelatine 75
Who's the Leader, Mania or Depression? Predominant Polarity and Alcohol/Polysubstance Use in Bipolar Disorders 75
Chronic ketamine use increases serum levels of brain-derived neurotrophic factor. 71
Gabapentin as add-on treatment for somatoform disorder: a case report 69
Poprawa nastroju u chorych na padaczke leczonych okskarbazepina 69
Quetiapine decreases alcohol consumption, craving, and psychiatric symptoms in dually diagnosed alcoholics 68
Ecstasy (MDMA)-addicted subjects show increased serum levels of brain-derived neurotrophic factor, independently from a rise of drug-induced psychotic symptoms 68
Anhedonia in Parkinson's disease patients with and without pathological gambling: a case-control study 68
Does DRD2 Taq1A Mediate Aripiprazole-Induced Gambling Disorder? A Pharmacogenetic Hypothesis 67
Mono- and polysubstance dependent subjects differ on social factors, childhood trauma, personality, suicidal behaviour, and comorbid Axis I diagnoses 66
Alcohol drinking patterns in young people: A survey-based study 66
Paliperidone for treatment of obsessive compulsive resistant symptoms in schizophrenia: a case report. 64
Management of aripiprazole-induced tardive Pisa syndrome: A case report and literature review 63
Striatal presynaptic dopaminergic dysfunction in gambling disorder: A 123 I-FP-CIT SPECT study. 60
Striatal presynaptic dopaminergic dysfunction in gambling disorder: A 123I-FP-CIT SPECT study 60
Reduced fronto-temporal connectivity is associated with frontal gray matter density reduction and neuropsychological deficit in schizophrenia. 59
Neuropsychological Performance in Alcohol Dependent Patients: A One-Year Longitudinal Study. 59
Harm avoidance moderates the influence of serotonin transporter gene variants on treatment outcome in bipolar patients 58
Pregabalin for alcohol dependence: a critical review of the literature 58
Transcranial electrical and magnetic stimulation (tES and TMS) for addiction medicine: A consensus paper on the present state of the science and the road ahead 58
Empathy ability is impaired in alcohol-dependent patients 57
BDNF Val66Met polymorphism is associated with aggressive behavior in schizophrenia 57
Agomelatine versus venlafaxine XR in the treatment of anhedonia in major depressive disorder: a pilot study 56
Dorsolateral Prefrontal Cortex Impairment in Methoxetamine-Induced Psychosis: An 18F-FDG PET/CT Case Study. 56
Nalmefene in Alcohol Use Disorder Subjects with Psychiatric Comorbidity: A Naturalistic Study. 54
Efficacy and safety of pregabalin in alcohol dependence 53
Ecstasy (MDMA)-addicted subjects show increased serum levels of brain-derived neurotrophic factor, independently from a rise of drug-induced psychotic symptoms. 53
Relationship between craving and plasma leptin concentrations in patients with cocaine addiction. 52
Prevalence and intensity of basic symptoms among cannabis users: an observational study 51
Psychosis in women: Time for personalized treatment 51
Substance-related psychopathology and aggressiveness in a nightlife holiday resort: Results from a pilot study in a psychiatric inpatient unit in Ibiza 48
Anhedonia and substance dependence: clinical correlates and treatment options 46
Temperament and character inventory dimensions and anhedonia in detoxified substance-dependent subjects 44
Trends in alcohol-related deaths in the EU countries in 1980-2003 35
Hopelessness, Dissociative Symptoms, and Suicide Risk in Major Depressive Disorder: Clinical and Biological Correlates 21
Totale 11.829
Categoria #
all - tutte 37.540
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.540


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020653 0 0 0 0 0 88 134 55 65 48 142 121
2020/20211.167 89 119 41 111 159 51 160 32 128 101 144 32
2021/20221.030 80 91 33 53 59 44 52 176 64 69 132 177
2022/20232.918 279 309 204 366 210 278 191 302 357 100 170 152
2023/20241.910 143 358 103 141 125 246 84 105 78 115 192 220
2024/20251.060 172 145 218 171 268 86 0 0 0 0 0 0
Totale 11.829